Volume Spike Investor

AVI BioPharma Inc. (Nasdaq: AVII) shares are down 9 percent to $2.15 in premarket trade of about 36,000 shares, counting it among the market’s most active as of 8:30 a.m. Eastern. The company filed a shelf registration statement with the SEC.

See previous story that warned of rising AVII short interest.